Literature DB >> 22494702

Neurotrophic factors in obsessive-compulsive disorder.

Leonardo F Fontenelle1, Izabela Guimarães Barbosa, Juliano Victor Luna, Natalia Pessoa Rocha, Aline Silva Miranda, Antonio Lucio Teixeira.   

Abstract

In this cross-sectional study, we assessed the levels of neurotrophins (NF) of patients with obsessive-compulsive disorder (OCD) in different stages of treatment and their relationship with OCD clinical features. Forty patients with OCD and 40 healthy controls had Brain-Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), and Glial Cell-Derived Neurotrophic Factor (GNDF) plasma levels measured by enzyme-linked immunosorbent assay (ELISA). Patients with OCD were further examined with the Obsessive-Compulsive Inventory-Revised, the Beck Depression Inventory, the Beck Anxiety Inventory, and the Sheehan Disability Scale (SDS). Patients with OCD exhibited significantly lower levels of BDNF and significantly increased levels of NGF as compared to healthy controls. In OCD, statistically significant negative correlations between BDNF levels and number of working days lost per week were found. Additional analyses revealed a statistically significant positive correlation between both NGF and GDNF and severity of washing symptoms. Plasma levels of NF were not affected by age, age at OCD onset, gender, major depressive disorder, the relative dose of serotonin-reuptake inhibitors being prescribed, or the use of antipsychotics. Our findings suggest that patients with OCD may exhibit a particular NF profile, with functional impairment correlating with BDNF levels and severity of washing symptoms correlating with NGF and GDNF levels.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22494702     DOI: 10.1016/j.psychres.2012.03.034

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

2.  Dietary choline supplementation to dams during pregnancy and lactation mitigates the effects of in utero stress exposure on adult anxiety-related behaviors.

Authors:  Kalynn M Schulz; Jennifer N Pearson; Mary E Gasparrini; Kayla F Brooks; Chakeer Drake-Frazier; Megan E Zajkowski; Alison D Kreisler; Catherine E Adams; Sherry Leonard; Karen E Stevens
Journal:  Behav Brain Res       Date:  2014-03-24       Impact factor: 3.332

3.  Neurotrophic factors, clinical features and gender differences in depression.

Authors:  Taiane de Azevedo Cardoso; Thaise Campos Mondin; Carolina David Wiener; Melina Bazili Marques; Briane de Ávila Fucolo; Ricardo Tavares Pinheiro; Luciano Dias Mattos de Souza; Ricardo Azevedo da Silva; Karen Jansen; Jean Pierre Oses
Journal:  Neurochem Res       Date:  2014-06-05       Impact factor: 3.996

4.  Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review.

Authors:  Yen-Wen Chen; Pao-Yen Lin; Kun-Yu Tu; Yu-Shian Cheng; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

Review 5.  Patient-reported outcomes in obsessive-compulsive disorder.

Authors:  Mythily Subramaniam; Pauline Soh; Clarissa Ong; Lee Seng Esmond Seow; Louisa Picco; Janhavi Ajit Vaingankar; Siow Ann Chong
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

6.  Mental disorders, functional impairment, and nerve growth factor.

Authors:  Fanny Helena Martins Salles; Pedro San Martin Soares; Carolina David Wiener; Thaise Campos Mondin; Paula Moraes da Silva; Karen Jansen; Luciano Dias de Mattos Souza; Ricardo Azevedo da Silva; Jean Pierre Oses
Journal:  Psychol Res Behav Manag       Date:  2016-12-22

7.  Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children.

Authors:  Ayhan Bilgiç; Merve Sertdemir; İbrahim Kılınç; Ömer Faruk Akça
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

8.  Investigating the Role of Hippocampal BDNF in Anxiety Vulnerability Using Classical Eyeblink Conditioning.

Authors:  Kellie L Janke; Tara P Cominski; Eldo V Kuzhikandathil; Richard J Servatius; Kevin C H Pang
Journal:  Front Psychiatry       Date:  2015-07-24       Impact factor: 4.157

9.  Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit.

Authors:  Fabricio H Do-Monte; Jose Rodriguez-Romaguera; Luis E Rosas-Vidal; Gregory J Quirk
Journal:  Front Behav Neurosci       Date:  2013-08-08       Impact factor: 3.558

10.  No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.

Authors:  Hidehiro Umehara; Shusuke Numata; Makoto Kinoshita; Shinya Watanabe; Shutaro Nakaaki; Satsuki Sumitani; Tetsuro Ohmori
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.